Novo Nordisk Pharmatech and Novozymes enter into enzyme partnership
Going forward, Novo Nordisk Pharmatech and Novozymes will collaborate on developing enzymes to be used in biotechnological drug development.
by marketwire, translated by daniel pedersen
Novo Nordisk Pharmatech and Novozymes have partnered up to developed specialty enzymes meant for biopharma processing and regenerative medicines, the firms announce in a shared press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
